allowing an investor to gain exposure to the trends within that segment. According to data from Benzinga Pro, ONCO has a 52-week high of $21.40 and a 52-week low of $0.06.

CINCINNATI, April 08, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) (formerly Blue Water Biotech Inc.) and Ocuvex ...